July low of $25.10 needs to hold, page-26

Thanks for the reply cafa.

I guess my point is if you have a legitimate reason for believing dose sales are 10% then would be great to hear it but if its based off the movement of the share price then I don't really pay much attention to that.

For example I seem to recall the share price rising strongly before a certain trial result was disclosed and we all know how that ended.

I do empathise with you regarding the position in your SMSF however.